Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis

Arthritis Research and Therapy

Volumn 8, Issue 3, 2006, Pages

  Bramlage, Carsten P ^a   Häupl, Thomas ^b   Kaps, Christian ^b   Ungethüm, Ute ^b   Krenn, Veit ^c   Pruss, Axel ^b   Müller, Gerhard A ^a   Strutz, Frank ^a   Burmester, Gerd R ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Institute of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BMP4 PROTEIN, HUMAN; BMP5 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; RNA;

ADULT; AGED; DNA MICROARRAY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; REFERENCE VALUES; RNA; SYNOVIAL MEMBRANE; TRANSCRIPTION, GENETIC;

EID: 70350539550     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1923     Document Type: Article

References (35)

1. Keyszer G, Redlich A, Häupl T, Zacher J, Sparmann M, Engethum U, Gay S, Burmester GR: Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: A parallel investigation by semiquantitative reverse transcriptase- polymerase chain reaction and immunohistochemistry. Arthritis Rheum 1998, 41:1378-1387.
2. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M: Synovitis: A potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005, 13:361-367.
3. van den Berg WB: Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol 1998, 20 149-164.
4. van der Kraan PM, van den Berg WB: Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 2000, 3 205-211.
5. Kaps C, Bramlage C, Smolian H, Haisch A, Ungethum U, Burmester GR, Sittinger M, Gross G, Häupl T: Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum 2002, 46:149-162.
6. Southwood LL, Frisbie DD, Kawcak CE, McIlwraith CW: Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg 2004, 33:565-578.
7. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S: Osteogenic protein- 1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83-A(Suppl 1):S151-S158.
8. Lories RJ, Derese I, Luyten FP: Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005, 115:1571-1579.
9. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB: Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 1998, 6:306-317.
10. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB: Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003, 48:3442-3451.
11. Chubinskaya S, Kuettner KE: Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 2003, 35:1323-1340.
12. Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelletier J: Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004, 50:2521-2530.
13. Ducy P, Karsenty G: The family of bone morphogenetic proteins. Kidney Int 2000, 57:2207-2214.
14. Sakou T: Bone morphogenFtic proteins: from basic studies to clinical approaches. Bone 1998, 22:591-603.
15. Kingsley DM: The TGFNbeta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146.
16. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992, 32:160-167.
17. Tsumaki N, Nakase T, Miyaji T, Kakiuchi M, Kimura T, Ochi T, Yoshikawa H: Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res 2002, 17:898-906.
18. Lories RJ, Derese I, Ceuppens JL, Luyten FP: Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003, 48:2807-2818.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
20. Krenn V, Morawietz L, Burmester GR, Häupl T: Synovitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovitis. Z Rheumatol 2005, 64:334-342.
21. Synovitis-Score [http://www.charite.de/ch/patho/Webpage/pages/ diagnostik/biopsie/synovitis/synovitis.htm]
22. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
24. Franz JK, Kolb SA, Hummel KM, Lahrtz F, Neidhart M, Aicher WK, Pap T, Gay RE, Fontana A, Gay S: Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol 1998, 28:2661-2671.
25. Koziolek MJ, Riess R, Geiger H, Thevenod F, Hauser IA: Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients. Kidney Int 2001, 60 156-166.
26. van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB: Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, b 50:103-111.
27. Archer CW, Dowthwaite GP, Francis-West P: Development of synovial joints. Birth Defects Res C Embryo Today 2003, 69:144-155.
28. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ: Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 2005, 320:269-276.
29. Schmitt B, Ringe J, Häupl T, Notter M, Manz R, Burmester GR, Sittinger M, Kaps C: BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in highdensity culture. Differentiation 2003, 71:567-577.
30. Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KE: Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002, 1588:126-134.
31. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ: Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 2003, 85-A(Suppl 3):59-66.
32. Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen JS, Graninger WB: Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 2003, 48:2501-2508.
33. Bobacz K, Hayer S, Smolen JS, Schett G: Expression of distinct members of the bone morphogenetic protein family is decreased in cartilage from chronically inflamed joints (abstract). Ann Rheum Dis 2004, 63:THK0178.
34. Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB: Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:627-635.
35. Pagura SM, Thomas SG, Woodhouse LJ, Ezzat S, Marks P: Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men J Orthop Res 2005, 23:397-405.